Analysen von Matthew Weston
| 09.09.24 | Roche Neutral | UBS AG | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
| 06.08.24 | Merck Buy | UBS AG | |
| 01.08.24 | Merck Buy | UBS AG | |
| 29.07.24 | Merck Buy | UBS AG | |
| 26.07.24 | Roche Neutral | UBS AG | |
|
Werbung
|
|||
| 26.07.24 | AstraZeneca Sell | UBS AG | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 19.07.24 | Sartorius vz. Neutral | UBS AG | |
| 10.07.24 | Roche Neutral | UBS AG | |
| 10.07.24 | Merck Buy | UBS AG | |
| 10.07.24 | Sartorius vz. Neutral | UBS AG | |
| 09.07.24 | Roche Neutral | UBS AG | |
| 04.07.24 | Roche Neutral | UBS AG | |
| 02.07.24 | Sartorius vz. Neutral | UBS AG | |
| 25.06.24 | Merck Buy | UBS AG | |
| 20.06.24 | Roche Neutral | UBS AG | |
| 20.06.24 | Sartorius vz. Neutral | UBS AG | |
| 04.06.24 | AstraZeneca Sell | UBS AG | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Roche Neutral | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 23.05.24 | Merck Buy | UBS AG | |
| 21.05.24 | AstraZeneca Sell | UBS AG | |
| 17.05.24 | Roche Neutral | UBS AG | |
| 16.05.24 | Sartorius vz. Neutral | UBS AG | |
| 15.05.24 | Merck Buy | UBS AG | |
| 15.05.24 | AstraZeneca Sell | UBS AG | |
| 14.05.24 | Roche Neutral | UBS AG | |
| 08.05.24 | Merck Buy | UBS AG | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Sartorius vz. Neutral | UBS AG | |
| 17.04.24 | Sartorius vz. Neutral | UBS AG | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 26.03.24 | Merck Buy | UBS AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 20.03.24 | Roche Neutral | UBS AG | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |